Topic

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Articles

FDA wants industry to talk to them about the science underlying process innovations-really.

A Very Brady FDA

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

Report from Brazil May 2010

Enterprise-Level Change Control

Editors' Picks of pharmaceutical science and technology innovations

In the Spotlight May 2010

Angie Drakulich was editorial director of Pharmaceutical Technology.

Agreement on standards for excipient qualification, development, and fair pricing is underway.

Inactive Excipients and Other Myths

When vessels, seals, and cooling units go haywire, operators must get in the mix.

Mixed Blessings

The author proposes techniques, based on Six Sigma methods, for monitoring such processes to discover their airflow patterns and reduce opportunities for spillage.This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."

Spillage Prevention and Airflow-Pattern Monitoring for High-Shear Process Operations

Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

Week Of April 26, 2010: Company And People Notes: Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Week Of April 19, 2010: Company And People Notes: FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the April 2010 edition from Camfil Farr and K-Tron.

Data and Artificial Intelligence